SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-022256
Filing Date
2017-11-07
Accepted
2017-11-07 16:19:28
Documents
44
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aldr-10q_20170930.htm 10-Q 1577670
2 EX-31.1 aldr-ex311_7.htm EX-31.1 15518
3 EX-31.2 aldr-ex312_6.htm EX-31.2 15544
4 EX-32.1 aldr-ex321_8.htm EX-32.1 8727
  Complete submission text file 0001564590-17-022256.txt   4244781

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aldr-20170930.xml EX-101.INS 864457
6 XBRL TAXONOMY EXTENSION SCHEMA aldr-20170930.xsd EX-101.SCH 25904
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldr-20170930_cal.xml EX-101.CAL 39253
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldr-20170930_def.xml EX-101.DEF 39045
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldr-20170930_lab.xml EX-101.LAB 174525
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldr-20170930_pre.xml EX-101.PRE 126986
Mailing Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011
Business Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011 425-205-2900
ALDER BIOPHARMACEUTICALS INC (Filer) CIK: 0001423824 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36431 | Film No.: 171183608
SIC: 2834 Pharmaceutical Preparations